Asia Pacific Veterinary Vaccines Market Size and Forecast (2021 - 2031)
The Asia Pacific Veterinary Vaccines Market is projected to experience significant growth, with an expected market size of approximately US$ 4,520.4 million by 2031, up from US$ 2,556.7 million in 2024. This growth translates to a compound annual growth rate (CAGR) of 8.5% from 2025 to 2031.
Executive Summary and Market Analysis
The veterinary vaccines market in the Asia Pacific region is categorized into several segments, including key countries such as China, Japan, India, Australia, South Korea, and other nations in the region. The market is anticipated to grow considerably during the forecast period, driven by robust government support and proactive initiatives from market players aimed at enhancing animal health management. Countries like Australia, India, and South Korea are identified as having substantial growth potential due to advancements in vaccine development, improvements in veterinary healthcare infrastructure, and increasing livestock populations.
Governments across the Asia Pacific are implementing policies to promote the widespread adoption of veterinary vaccination programs, which are crucial for controlling infectious and zoonotic diseases affecting animals. The rising incidence of chronic zoonotic infections that impact both animals and humans is further fueling the demand for effective veterinary vaccines. Additionally, growing awareness regarding animal welfare and disease prevention is expected to enhance the outlook for the Asia Pacific veterinary vaccines market, positioning the region as a significant growth area in the global veterinary vaccine landscape.
Strategic Insights
Market Segmentation Analysis
The Asia Pacific Veterinary Vaccines Market is segmented based on various criteria:
The expansion of manufacturing plants represents a significant growth opportunity for the veterinary vaccines market. This expansion addresses critical issues such as production scalability, cost reduction, and improved accessibility of vaccines in the region. The increasing demand for veterinary vaccines, driven by rising pet ownership, livestock management needs, and international disease prevention initiatives, has prompted producers to invest in new facilities and upgrade existing ones to enhance production capacity.
For instance, in March 2024, Zoetis announced the acquisition of a 21-acre production facility in Melbourne to expand its operations and increase future capacity for developing vaccines for various animals, including sheep, cattle, dogs, cats, and horses. Similarly, in December 2023, Indian Immunologicals Limited (IIL) began constructing a new veterinary vaccine manufacturing facility in Genome Valley, Hyderabad, with an investment of Rs.700 crore (approximately US$ 82.74 million). This facility aims to produce the Foot and Mouth Disease vaccine and a combination vaccine for Foot and Mouth Disease and Haemorrhagic Septicaemia, creating over 750 jobs.
In 2024, Vaksindo Vietnam Co Ltd inaugurated a state-of-the-art veterinary vaccine factory in Y?n My II Industrial Park, Hung Y?n Province, which is certified to GMP-WHO standards and produces various vaccines targeting pigs, cattle, and poultry. These expansions not only increase supply to meet global demand but also reduce production costs through economies of scale. Local manufacturing facilities ensure faster distribution and lower reliance on imports, particularly in developing countries like India.
Country Insights
The Asia Pacific Veterinary Vaccines Market is further segmented by country, with Japan holding the largest market share in 2024. The Japanese government has long recognized the importance of animal health, implementing vaccination programs for diseases such as avian influenza and Foot and Mouth Disease (FMD). The Ministry of Agriculture, Forestry, and Fisheries (MAFF) in Japan has established strict surveillance and biosecurity measures to support these vaccination efforts.
Private pharmaceutical companies in Japan also play a crucial role in developing vaccines tailored to the livestock industry's needs. For example, in 2021, Meiji Seika Pharma launched a vaccine aimed at reducing mortality rates and clinical symptoms of Swine edema disease in pigs.
Company Profiles
Key players in the Asia Pacific Veterinary Vaccines Market include Merck & Co Inc, Boehringer Ingelheim International GmbH, Ceva Sant? Animale, Zoetis Inc, Elanco Animal Health Inc, Virbac SA, Neogen Corp, Hester Biosciences Ltd, HIPRA SA, and Biovac LTD. These companies are employing various strategies, including expansion, product innovation, and mergers and acquisitions, to enhance their product offerings and increase market share.
Executive Summary and Market Analysis
The veterinary vaccines market in the Asia Pacific region is categorized into several segments, including key countries such as China, Japan, India, Australia, South Korea, and other nations in the region. The market is anticipated to grow considerably during the forecast period, driven by robust government support and proactive initiatives from market players aimed at enhancing animal health management. Countries like Australia, India, and South Korea are identified as having substantial growth potential due to advancements in vaccine development, improvements in veterinary healthcare infrastructure, and increasing livestock populations.
Governments across the Asia Pacific are implementing policies to promote the widespread adoption of veterinary vaccination programs, which are crucial for controlling infectious and zoonotic diseases affecting animals. The rising incidence of chronic zoonotic infections that impact both animals and humans is further fueling the demand for effective veterinary vaccines. Additionally, growing awareness regarding animal welfare and disease prevention is expected to enhance the outlook for the Asia Pacific veterinary vaccines market, positioning the region as a significant growth area in the global veterinary vaccine landscape.
Strategic Insights
Market Segmentation Analysis
The Asia Pacific Veterinary Vaccines Market is segmented based on various criteria:
- By Technology: The market is divided into Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, Toxoid Vaccines, and Others. Live Attenuated Vaccines are projected to hold the largest market share in 2024.
- By Animal Type: The market is categorized into Companion Animals and Livestock & Poultry, with Livestock and Poultry expected to dominate the market share in 2024.
- By Companion Animals: This segment includes Dogs, Cats, Horses, and Others, with Dogs anticipated to hold the largest share.
- By Livestock and Poultry: This includes Chicken, Cattle, and Others, where Chicken is expected to lead the market.
- By Route of Administration: The market is segmented into Intramuscular, Subcutaneous, and Others, with Intramuscular administration projected to hold the largest share.
- By End User: This includes Veterinary Hospitals, Veterinary Clinics, and Others, with Veterinary Hospitals expected to dominate the market.
The expansion of manufacturing plants represents a significant growth opportunity for the veterinary vaccines market. This expansion addresses critical issues such as production scalability, cost reduction, and improved accessibility of vaccines in the region. The increasing demand for veterinary vaccines, driven by rising pet ownership, livestock management needs, and international disease prevention initiatives, has prompted producers to invest in new facilities and upgrade existing ones to enhance production capacity.
For instance, in March 2024, Zoetis announced the acquisition of a 21-acre production facility in Melbourne to expand its operations and increase future capacity for developing vaccines for various animals, including sheep, cattle, dogs, cats, and horses. Similarly, in December 2023, Indian Immunologicals Limited (IIL) began constructing a new veterinary vaccine manufacturing facility in Genome Valley, Hyderabad, with an investment of Rs.700 crore (approximately US$ 82.74 million). This facility aims to produce the Foot and Mouth Disease vaccine and a combination vaccine for Foot and Mouth Disease and Haemorrhagic Septicaemia, creating over 750 jobs.
In 2024, Vaksindo Vietnam Co Ltd inaugurated a state-of-the-art veterinary vaccine factory in Y?n My II Industrial Park, Hung Y?n Province, which is certified to GMP-WHO standards and produces various vaccines targeting pigs, cattle, and poultry. These expansions not only increase supply to meet global demand but also reduce production costs through economies of scale. Local manufacturing facilities ensure faster distribution and lower reliance on imports, particularly in developing countries like India.
Country Insights
The Asia Pacific Veterinary Vaccines Market is further segmented by country, with Japan holding the largest market share in 2024. The Japanese government has long recognized the importance of animal health, implementing vaccination programs for diseases such as avian influenza and Foot and Mouth Disease (FMD). The Ministry of Agriculture, Forestry, and Fisheries (MAFF) in Japan has established strict surveillance and biosecurity measures to support these vaccination efforts.
Private pharmaceutical companies in Japan also play a crucial role in developing vaccines tailored to the livestock industry's needs. For example, in 2021, Meiji Seika Pharma launched a vaccine aimed at reducing mortality rates and clinical symptoms of Swine edema disease in pigs.
Company Profiles
Key players in the Asia Pacific Veterinary Vaccines Market include Merck & Co Inc, Boehringer Ingelheim International GmbH, Ceva Sant? Animale, Zoetis Inc, Elanco Animal Health Inc, Virbac SA, Neogen Corp, Hester Biosciences Ltd, HIPRA SA, and Biovac LTD. These companies are employing various strategies, including expansion, product innovation, and mergers and acquisitions, to enhance their product offerings and increase market share.
1. INTRODUCTION
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. VETERINARY VACCINES MARKET LANDSCAPE
4.1 Market Overview
4.2 PEST Analysis
5. ASIA PACIFIC VETERINARY VACCINES MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. VETERINARY VACCINES MARKET - ASIA PACIFIC MARKET ANALYSIS
6.1 Asia Pacific Veterinary Vaccines Market Revenue (US$ Million), 2024 - 2031
6.2 Asia Pacific Veterinary Vaccines Market Forecast and Analysis
7. ASIA PACIFIC VETERINARY VACCINES MARKET REVENUE ANALYSIS - BY TECHNOLOGY
7.1 Live Attenuated Vaccines
7.1.1 Overview
7.1.2 Live Attenuated Vaccines: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Inactivated Vaccines
7.2.1 Overview
7.2.2 Inactivated Vaccines: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Recombinant Vaccines
7.3.1 Overview
7.3.2 Recombinant Vaccines: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Toxoid Vaccines
7.4.1 Overview
7.4.2 Toxoid Vaccines: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. ASIA PACIFIC VETERINARY VACCINES MARKET REVENUE ANALYSIS - BY ANIMAL TYPE
8.1 Companion
8.1.1 Overview
8.1.2 Companion: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Livestock and Poultry
8.2.1 Overview
8.2.2 Livestock and Poultry: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. ASIA PACIFIC VETERINARY VACCINES MARKET REVENUE ANALYSIS - BY COMPANION
9.1 Dogs
9.1.1 Overview
9.1.2 Dogs: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Cat
9.2.1 Overview
9.2.2 Cat: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Horses
9.3.1 Overview
9.3.2 Horses: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.4 Others
9.4.1 Overview
9.4.2 Others: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. ASIA PACIFIC VETERINARY VACCINES MARKET REVENUE ANALYSIS - BY LIVESTOCK AND POULTRY
10.1 Chicken
10.1.1 Overview
10.1.2 Chicken: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 Cattle
10.2.1 Overview
10.2.2 Cattle: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 Others
10.3.1 Overview
10.3.2 Others: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11. ASIA PACIFIC VETERINARY VACCINES MARKET REVENUE ANALYSIS - BY ROUTE OF ADMINISTRATION
11.1 Intramuscular
11.1.1 Overview
11.1.2 Intramuscular: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2 Subcutaneous
11.2.1 Overview
11.2.2 Subcutaneous: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.3 Others
11.3.1 Overview
11.3.2 Others: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12. ASIA PACIFIC VETERINARY VACCINES MARKET REVENUE ANALYSIS - BY END USER
12.1 Veterinary Hospitals
12.1.1 Overview
12.1.2 Veterinary Hospitals: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.2 Veterinary Clinics
12.2.1 Overview
12.2.2 Veterinary Clinics: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.3 Others
12.3.1 Overview
12.3.2 Others: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13. ASIA PACIFIC VETERINARY VACCINES MARKET - COUNTRY ANALYSIS
13.1 Asia Pacific
13.1.1 Asia Pacific Veterinary Vaccines Market Revenue and Forecast and Analysis - by Country
13.1.1.1 Asia Pacific Veterinary Vaccines Market Revenue and Forecast and Analysis - by Country
13.1.2.2 China: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.1.2.2.1 China: Asia Pacific Veterinary Vaccines Market Share - by Technology
13.1.2.2.2 China: Asia Pacific Veterinary Vaccines Market Share - by Animal Type
13.1.2.2.3 China: Asia Pacific Veterinary Vaccines Market Share - by Companion
13.1.2.2.4 China: Asia Pacific Veterinary Vaccines Market Share - by Livestock And Poultry
13.1.2.2.5 China: Asia Pacific Veterinary Vaccines Market Share - by Route Of Administration
13.1.2.2.6 China: Asia Pacific Veterinary Vaccines Market Share - by End User
13.2.3.3 Japan: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.2.3.3.1 Japan: Asia Pacific Veterinary Vaccines Market Share - by Technology
13.2.3.3.2 Japan: Asia Pacific Veterinary Vaccines Market Share - by Animal Type
13.2.3.3.3 Japan: Asia Pacific Veterinary Vaccines Market Share - by Companion
13.2.3.3.4 Japan: Asia Pacific Veterinary Vaccines Market Share - by Livestock And Poultry
13.2.3.3.5 Japan: Asia Pacific Veterinary Vaccines Market Share - by Route Of Administration
13.2.3.3.6 Japan: Asia Pacific Veterinary Vaccines Market Share - by End User
13.3.4.4 India: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.3.4.4.1 India: Asia Pacific Veterinary Vaccines Market Share - by Technology
13.3.4.4.2 India: Asia Pacific Veterinary Vaccines Market Share - by Animal Type
13.3.4.4.3 India: Asia Pacific Veterinary Vaccines Market Share - by Companion
13.3.4.4.4 India: Asia Pacific Veterinary Vaccines Market Share - by Livestock And Poultry
13.3.4.4.5 India: Asia Pacific Veterinary Vaccines Market Share - by Route Of Administration
13.3.4.4.6 India: Asia Pacific Veterinary Vaccines Market Share - by End User
13.4.5.5 Australia: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.4.5.5.1 Australia: Asia Pacific Veterinary Vaccines Market Share - by Technology
13.4.5.5.2 Australia: Asia Pacific Veterinary Vaccines Market Share - by Animal Type
13.4.5.5.3 Australia: Asia Pacific Veterinary Vaccines Market Share - by Companion
13.4.5.5.4 Australia: Asia Pacific Veterinary Vaccines Market Share - by Livestock And Poultry
13.4.5.5.5 Australia: Asia Pacific Veterinary Vaccines Market Share - by Route Of Administration
13.4.5.5.6 Australia: Asia Pacific Veterinary Vaccines Market Share - by End User
13.5.6.6 South Korea: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.5.6.6.1 South Korea: Asia Pacific Veterinary Vaccines Market Share - by Technology
13.5.6.6.2 South Korea: Asia Pacific Veterinary Vaccines Market Share - by Animal Type
13.5.6.6.3 South Korea: Asia Pacific Veterinary Vaccines Market Share - by Companion
13.5.6.6.4 South Korea: Asia Pacific Veterinary Vaccines Market Share - by Livestock And Poultry
13.5.6.6.5 South Korea: Asia Pacific Veterinary Vaccines Market Share - by Route Of Administration
13.5.6.6.6 South Korea: Asia Pacific Veterinary Vaccines Market Share - by End User
13.6.7.7 Rest of APAC: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.6.7.7.1 Rest of APAC: Asia Pacific Veterinary Vaccines Market Share - by Technology
13.6.7.7.2 Rest of APAC: Asia Pacific Veterinary Vaccines Market Share - by Animal Type
13.6.7.7.3 Rest of APAC: Asia Pacific Veterinary Vaccines Market Share - by Companion
13.6.7.7.4 Rest of APAC: Asia Pacific Veterinary Vaccines Market Share - by Livestock And Poultry
13.6.7.7.5 Rest of APAC: Asia Pacific Veterinary Vaccines Market Share - by Route Of Administration
13.6.7.7.6 Rest of APAC: Asia Pacific Veterinary Vaccines Market Share - by End User
15 INDUSTRY LANDSCAPE
15.1 Overview
15.2 New Product Development
15.3 Merger and Acquisition
15.4 Other Strategic Developments
16 COMPANY PROFILES
16.1 Merck & Co Inc
16.1.1 Key Facts
16.1.2 Business Description
16.1.3 Products and Services
16.1.4 Financial Overview
16.1.5 SWOT Analysis
16.1.6 Key Developments
16.2 Boehringer Ingelheim International GmbH
16.2.1 Key Facts
16.2.2 Business Description
16.2.3 Products and Services
16.2.4 Financial Overview
16.2.5 SWOT Analysis
16.2.6 Key Developments
16.3 Ceva Sant? Animale
16.3.1 Key Facts
16.3.2 Business Description
16.3.3 Products and Services
16.3.4 Financial Overview
16.3.5 SWOT Analysis
16.3.6 Key Developments
16.4 Zoetis Inc
16.4.1 Key Facts
16.4.2 Business Description
16.4.3 Products and Services
16.4.4 Financial Overview
16.4.5 SWOT Analysis
16.4.6 Key Developments
16.5 Elanco Animal Health Inc
16.5.1 Key Facts
16.5.2 Business Description
16.5.3 Products and Services
16.5.4 Financial Overview
16.5.5 SWOT Analysis
16.5.6 Key Developments
16.6 Virbac SA
16.6.1 Key Facts
16.6.2 Business Description
16.6.3 Products and Services
16.6.4 Financial Overview
16.6.5 SWOT Analysis
16.6.6 Key Developments
16.7 Neogen Corp
16.7.1 Key Facts
16.7.2 Business Description
16.7.3 Products and Services
16.7.4 Financial Overview
16.7.5 SWOT Analysis
16.7.6 Key Developments
16.8 Hester Biosciences Ltd
16.8.1 Key Facts
16.8.2 Business Description
16.8.3 Products and Services
16.8.4 Financial Overview
16.8.5 SWOT Analysis
16.8.6 Key Developments
16.9 HIPRA SA
16.9.1 Key Facts
16.9.2 Business Description
16.9.3 Products and Services
16.9.4 Financial Overview
16.9.5 SWOT Analysis
16.9.6 Key Developments
16.10 Biovac LTD
16.10.1 Key Facts
16.10.2 Business Description
16.10.3 Products and Services
16.10.4 Financial Overview
16.10.5 SWOT Analysis
16.10.6 Key Developments
17. APPENDIX
17.1 About The Insight Partners
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. VETERINARY VACCINES MARKET LANDSCAPE
4.1 Market Overview
4.2 PEST Analysis
5. ASIA PACIFIC VETERINARY VACCINES MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. VETERINARY VACCINES MARKET - ASIA PACIFIC MARKET ANALYSIS
6.1 Asia Pacific Veterinary Vaccines Market Revenue (US$ Million), 2024 - 2031
6.2 Asia Pacific Veterinary Vaccines Market Forecast and Analysis
7. ASIA PACIFIC VETERINARY VACCINES MARKET REVENUE ANALYSIS - BY TECHNOLOGY
7.1 Live Attenuated Vaccines
7.1.1 Overview
7.1.2 Live Attenuated Vaccines: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Inactivated Vaccines
7.2.1 Overview
7.2.2 Inactivated Vaccines: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Recombinant Vaccines
7.3.1 Overview
7.3.2 Recombinant Vaccines: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Toxoid Vaccines
7.4.1 Overview
7.4.2 Toxoid Vaccines: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. ASIA PACIFIC VETERINARY VACCINES MARKET REVENUE ANALYSIS - BY ANIMAL TYPE
8.1 Companion
8.1.1 Overview
8.1.2 Companion: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Livestock and Poultry
8.2.1 Overview
8.2.2 Livestock and Poultry: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. ASIA PACIFIC VETERINARY VACCINES MARKET REVENUE ANALYSIS - BY COMPANION
9.1 Dogs
9.1.1 Overview
9.1.2 Dogs: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Cat
9.2.1 Overview
9.2.2 Cat: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Horses
9.3.1 Overview
9.3.2 Horses: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.4 Others
9.4.1 Overview
9.4.2 Others: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. ASIA PACIFIC VETERINARY VACCINES MARKET REVENUE ANALYSIS - BY LIVESTOCK AND POULTRY
10.1 Chicken
10.1.1 Overview
10.1.2 Chicken: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 Cattle
10.2.1 Overview
10.2.2 Cattle: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 Others
10.3.1 Overview
10.3.2 Others: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11. ASIA PACIFIC VETERINARY VACCINES MARKET REVENUE ANALYSIS - BY ROUTE OF ADMINISTRATION
11.1 Intramuscular
11.1.1 Overview
11.1.2 Intramuscular: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2 Subcutaneous
11.2.1 Overview
11.2.2 Subcutaneous: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.3 Others
11.3.1 Overview
11.3.2 Others: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12. ASIA PACIFIC VETERINARY VACCINES MARKET REVENUE ANALYSIS - BY END USER
12.1 Veterinary Hospitals
12.1.1 Overview
12.1.2 Veterinary Hospitals: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.2 Veterinary Clinics
12.2.1 Overview
12.2.2 Veterinary Clinics: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.3 Others
12.3.1 Overview
12.3.2 Others: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13. ASIA PACIFIC VETERINARY VACCINES MARKET - COUNTRY ANALYSIS
13.1 Asia Pacific
13.1.1 Asia Pacific Veterinary Vaccines Market Revenue and Forecast and Analysis - by Country
13.1.1.1 Asia Pacific Veterinary Vaccines Market Revenue and Forecast and Analysis - by Country
13.1.2.2 China: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.1.2.2.1 China: Asia Pacific Veterinary Vaccines Market Share - by Technology
13.1.2.2.2 China: Asia Pacific Veterinary Vaccines Market Share - by Animal Type
13.1.2.2.3 China: Asia Pacific Veterinary Vaccines Market Share - by Companion
13.1.2.2.4 China: Asia Pacific Veterinary Vaccines Market Share - by Livestock And Poultry
13.1.2.2.5 China: Asia Pacific Veterinary Vaccines Market Share - by Route Of Administration
13.1.2.2.6 China: Asia Pacific Veterinary Vaccines Market Share - by End User
13.2.3.3 Japan: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.2.3.3.1 Japan: Asia Pacific Veterinary Vaccines Market Share - by Technology
13.2.3.3.2 Japan: Asia Pacific Veterinary Vaccines Market Share - by Animal Type
13.2.3.3.3 Japan: Asia Pacific Veterinary Vaccines Market Share - by Companion
13.2.3.3.4 Japan: Asia Pacific Veterinary Vaccines Market Share - by Livestock And Poultry
13.2.3.3.5 Japan: Asia Pacific Veterinary Vaccines Market Share - by Route Of Administration
13.2.3.3.6 Japan: Asia Pacific Veterinary Vaccines Market Share - by End User
13.3.4.4 India: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.3.4.4.1 India: Asia Pacific Veterinary Vaccines Market Share - by Technology
13.3.4.4.2 India: Asia Pacific Veterinary Vaccines Market Share - by Animal Type
13.3.4.4.3 India: Asia Pacific Veterinary Vaccines Market Share - by Companion
13.3.4.4.4 India: Asia Pacific Veterinary Vaccines Market Share - by Livestock And Poultry
13.3.4.4.5 India: Asia Pacific Veterinary Vaccines Market Share - by Route Of Administration
13.3.4.4.6 India: Asia Pacific Veterinary Vaccines Market Share - by End User
13.4.5.5 Australia: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.4.5.5.1 Australia: Asia Pacific Veterinary Vaccines Market Share - by Technology
13.4.5.5.2 Australia: Asia Pacific Veterinary Vaccines Market Share - by Animal Type
13.4.5.5.3 Australia: Asia Pacific Veterinary Vaccines Market Share - by Companion
13.4.5.5.4 Australia: Asia Pacific Veterinary Vaccines Market Share - by Livestock And Poultry
13.4.5.5.5 Australia: Asia Pacific Veterinary Vaccines Market Share - by Route Of Administration
13.4.5.5.6 Australia: Asia Pacific Veterinary Vaccines Market Share - by End User
13.5.6.6 South Korea: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.5.6.6.1 South Korea: Asia Pacific Veterinary Vaccines Market Share - by Technology
13.5.6.6.2 South Korea: Asia Pacific Veterinary Vaccines Market Share - by Animal Type
13.5.6.6.3 South Korea: Asia Pacific Veterinary Vaccines Market Share - by Companion
13.5.6.6.4 South Korea: Asia Pacific Veterinary Vaccines Market Share - by Livestock And Poultry
13.5.6.6.5 South Korea: Asia Pacific Veterinary Vaccines Market Share - by Route Of Administration
13.5.6.6.6 South Korea: Asia Pacific Veterinary Vaccines Market Share - by End User
13.6.7.7 Rest of APAC: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.6.7.7.1 Rest of APAC: Asia Pacific Veterinary Vaccines Market Share - by Technology
13.6.7.7.2 Rest of APAC: Asia Pacific Veterinary Vaccines Market Share - by Animal Type
13.6.7.7.3 Rest of APAC: Asia Pacific Veterinary Vaccines Market Share - by Companion
13.6.7.7.4 Rest of APAC: Asia Pacific Veterinary Vaccines Market Share - by Livestock And Poultry
13.6.7.7.5 Rest of APAC: Asia Pacific Veterinary Vaccines Market Share - by Route Of Administration
13.6.7.7.6 Rest of APAC: Asia Pacific Veterinary Vaccines Market Share - by End User
15 INDUSTRY LANDSCAPE
15.1 Overview
15.2 New Product Development
15.3 Merger and Acquisition
15.4 Other Strategic Developments
16 COMPANY PROFILES
16.1 Merck & Co Inc
16.1.1 Key Facts
16.1.2 Business Description
16.1.3 Products and Services
16.1.4 Financial Overview
16.1.5 SWOT Analysis
16.1.6 Key Developments
16.2 Boehringer Ingelheim International GmbH
16.2.1 Key Facts
16.2.2 Business Description
16.2.3 Products and Services
16.2.4 Financial Overview
16.2.5 SWOT Analysis
16.2.6 Key Developments
16.3 Ceva Sant? Animale
16.3.1 Key Facts
16.3.2 Business Description
16.3.3 Products and Services
16.3.4 Financial Overview
16.3.5 SWOT Analysis
16.3.6 Key Developments
16.4 Zoetis Inc
16.4.1 Key Facts
16.4.2 Business Description
16.4.3 Products and Services
16.4.4 Financial Overview
16.4.5 SWOT Analysis
16.4.6 Key Developments
16.5 Elanco Animal Health Inc
16.5.1 Key Facts
16.5.2 Business Description
16.5.3 Products and Services
16.5.4 Financial Overview
16.5.5 SWOT Analysis
16.5.6 Key Developments
16.6 Virbac SA
16.6.1 Key Facts
16.6.2 Business Description
16.6.3 Products and Services
16.6.4 Financial Overview
16.6.5 SWOT Analysis
16.6.6 Key Developments
16.7 Neogen Corp
16.7.1 Key Facts
16.7.2 Business Description
16.7.3 Products and Services
16.7.4 Financial Overview
16.7.5 SWOT Analysis
16.7.6 Key Developments
16.8 Hester Biosciences Ltd
16.8.1 Key Facts
16.8.2 Business Description
16.8.3 Products and Services
16.8.4 Financial Overview
16.8.5 SWOT Analysis
16.8.6 Key Developments
16.9 HIPRA SA
16.9.1 Key Facts
16.9.2 Business Description
16.9.3 Products and Services
16.9.4 Financial Overview
16.9.5 SWOT Analysis
16.9.6 Key Developments
16.10 Biovac LTD
16.10.1 Key Facts
16.10.2 Business Description
16.10.3 Products and Services
16.10.4 Financial Overview
16.10.5 SWOT Analysis
16.10.6 Key Developments
17. APPENDIX
17.1 About The Insight Partners
LIST OF TABLES
Table 1. Asia Pacific Veterinary Vaccines Market Segmentation
Table 3. Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Technology
Table 5. Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Animal Type
Table 6. Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Companion
Table 7. Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Livestock And Poultry
Table 8. Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 9. Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 10. Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 11. China: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Technology
Table 12. China: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Animal Type
Table 13. China: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Companion
Table 14. China: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Livestock And Poultry
Table 15. China: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 16. China: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 17. Japan: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Technology
Table 18. Japan: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Animal Type
Table 19. Japan: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Companion
Table 20. Japan: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Livestock And Poultry
Table 21. Japan: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 22. Japan: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 23. India: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Technology
Table 24. India: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Animal Type
Table 25. India: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Companion
Table 26. India: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Livestock And Poultry
Table 27. India: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 28. India: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 29. Australia: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Technology
Table 30. Australia: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Animal Type
Table 31. Australia: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Companion
Table 32. Australia: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Livestock And Poultry
Table 33. Australia: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 34. Australia: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 35. South Korea: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Technology
Table 36. South Korea: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Animal Type
Table 37. South Korea: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Companion
Table 38. South Korea: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Livestock And Poultry
Table 39. South Korea: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 40. South Korea: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 41. Rest of APAC: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Technology
Table 42. Rest of APAC: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Animal Type
Table 43. Rest of APAC: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Companion
Table 44. Rest of APAC: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Livestock And Poultry
Table 45. Rest of APAC: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 46. Rest of APAC: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 1. Asia Pacific Veterinary Vaccines Market Segmentation
Table 3. Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Technology
Table 5. Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Animal Type
Table 6. Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Companion
Table 7. Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Livestock And Poultry
Table 8. Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 9. Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 10. Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 11. China: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Technology
Table 12. China: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Animal Type
Table 13. China: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Companion
Table 14. China: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Livestock And Poultry
Table 15. China: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 16. China: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 17. Japan: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Technology
Table 18. Japan: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Animal Type
Table 19. Japan: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Companion
Table 20. Japan: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Livestock And Poultry
Table 21. Japan: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 22. Japan: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 23. India: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Technology
Table 24. India: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Animal Type
Table 25. India: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Companion
Table 26. India: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Livestock And Poultry
Table 27. India: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 28. India: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 29. Australia: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Technology
Table 30. Australia: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Animal Type
Table 31. Australia: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Companion
Table 32. Australia: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Livestock And Poultry
Table 33. Australia: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 34. Australia: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 35. South Korea: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Technology
Table 36. South Korea: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Animal Type
Table 37. South Korea: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Companion
Table 38. South Korea: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Livestock And Poultry
Table 39. South Korea: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 40. South Korea: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 41. Rest of APAC: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Technology
Table 42. Rest of APAC: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Animal Type
Table 43. Rest of APAC: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Companion
Table 44. Rest of APAC: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Livestock And Poultry
Table 45. Rest of APAC: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 46. Rest of APAC: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
LIST OF FIGURES
Figure 1. Asia Pacific Veterinary Vaccines Market Segmentation - Country
Figure 2. PEST Analysis
Figure 4. Asia Pacific Veterinary Vaccines Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Asia Pacific Veterinary Vaccines Market Revenue (US$ Million), 2024 - 2031
Figure 7. Asia Pacific Veterinary Vaccines Market Share (%) - by Technology, 2024 and 2031
Figure 8. Live Attenuated Vaccines: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Inactivated Vaccines: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Recombinant Vaccines: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Toxoid Vaccines: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Others: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Asia Pacific Veterinary Vaccines Market Share (%) - by Animal Type, 2024 and 2031
Figure 14. Companion: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. Livestock and Poultry: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Asia Pacific Veterinary Vaccines Market Share (%) - by Companion, 2024 and 2031
Figure 17. Dogs: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Cat: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Horses: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 20. Others: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Asia Pacific Veterinary Vaccines Market Share (%) - by Livestock And Poultry, 2024 and 2031
Figure 22. Chicken: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. Cattle: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. Others: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Asia Pacific Veterinary Vaccines Market Share (%) - by Route Of Administration, 2024 and 2031
Figure 26. Intramuscular: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Subcutaneous: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 28. Others: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 29. Asia Pacific Veterinary Vaccines Market Share (%) - by End User, 2024 and 2031
Figure 30. Veterinary Hospitals: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 31. Veterinary Clinics: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 32. Others: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 33. Asia Pacific Veterinary Vaccines Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 34. China: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 35. Japan: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 36. India: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 37. Australia: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 38. South Korea: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 39. Rest of APAC: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 1. Asia Pacific Veterinary Vaccines Market Segmentation - Country
Figure 2. PEST Analysis
Figure 4. Asia Pacific Veterinary Vaccines Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Asia Pacific Veterinary Vaccines Market Revenue (US$ Million), 2024 - 2031
Figure 7. Asia Pacific Veterinary Vaccines Market Share (%) - by Technology, 2024 and 2031
Figure 8. Live Attenuated Vaccines: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Inactivated Vaccines: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Recombinant Vaccines: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Toxoid Vaccines: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Others: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Asia Pacific Veterinary Vaccines Market Share (%) - by Animal Type, 2024 and 2031
Figure 14. Companion: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. Livestock and Poultry: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Asia Pacific Veterinary Vaccines Market Share (%) - by Companion, 2024 and 2031
Figure 17. Dogs: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Cat: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Horses: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 20. Others: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Asia Pacific Veterinary Vaccines Market Share (%) - by Livestock And Poultry, 2024 and 2031
Figure 22. Chicken: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. Cattle: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. Others: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Asia Pacific Veterinary Vaccines Market Share (%) - by Route Of Administration, 2024 and 2031
Figure 26. Intramuscular: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Subcutaneous: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 28. Others: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 29. Asia Pacific Veterinary Vaccines Market Share (%) - by End User, 2024 and 2031
Figure 30. Veterinary Hospitals: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 31. Veterinary Clinics: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 32. Others: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 33. Asia Pacific Veterinary Vaccines Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 34. China: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 35. Japan: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 36. India: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 37. Australia: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 38. South Korea: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 39. Rest of APAC: Asia Pacific Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
